IP Library Granted Patent US 6,852,874
Granted Patent B2
US 6,852,874 · App. 09/941,410 · Granted Feb 8, 2005

Second cycle asymmetric dihydroxylation reaction

Assignee: The Scripps Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,852,874
App. No.
09/941,410
Granted
Feb 8, 2005
Kind
B2
Abstract

A process for catalyzing asymmetric dihydroxylations of olefins employs an Os(VI) complex as a catalytic intermediate in the formation of chiral vicinal diol products. The process requires a chiral bidentate ligand that favors diol formation in the “second cycle” of asymmetric dihydroxylation.

Claims (22)

1. A process for catalyzing a second-cycle asymmetric dihydroxylation reaction for converting an olefin substrate to a chiral vicinal diol product, said process comprising the following steps:

Step A: mixing the olefin substrate with a catalytic amount of a chiral bidentate ligand in an aqueous solvent, the aqueous solvent optionally being an alcohol/water solvent mixture, the chiral bidentate ligand being represented by the following structure:

wherein:

R is a radical selected from the group consisting of hydrogen, carboxylic acid, phenyl, 1-naphthyl, 2-naphthyl, alkyl(C 1 -C 12 ), cyclo-alkyl(C 3 -C 12 ), carbamoyl, N-alkyl(C 1 -C 12 ) carbamoyl, and N,N-alkyl(C 1 -C 12 ) carbamoyl, wherein the phenyl, 1-naphthyl, and 2-naphthyl radicals ay optionally have substituents in any available position;

R 1 is a radical selected from the group consisting of carboxylic acid, carbamoyl, N-alkyl(C 1 -C 12 ) carbamoyl, and N,N-dialkyl(C 1 -C 12 ) carbamoyl;

R 2 is a radical selected from the group consisting of hydrogen , alkyl(C 1 -C 12 ), aryl, and heteroaryl; and

X and Y are radicals independently selected from the group consisting of hydroxyl, amino, N-alkyl(C 1 -C 12 )sulfonylamino, N-arylsulfonylamino, and N-heteroarylsulfonylamino;

with the following provisos:

if X is not a hydroxyl group, then Y must be a hydroxy group;

if Y is not a hydroxyl group then X must be a hydroxyl group; and

at least one of the following must be a carboxylic acid group: R, R 1 or R 2 ; and then

Step B: adding to the mixture of said Step A a stoichiometric amount or a stoichimetric excess of N-methyl morpholine N-oxide with respect to the olefin substrate and a catalytic amount of osmium tetraoxide under reaction conditions for catalyzing the second-cycle asymmetric dihydroxylation reaction for converting the olefin substrate to the chiral vicinal diol product.

2. A process according to claim 1 where the chiral bidentate ligand is selected from the group represented by the following structures:

3. A process according to claim 1 wherein the chiral ligand is an α-hydroxy-β-N-sulfonylamino carboxylic acid.

4. A process according to claim 1 wherein the chiral ligand is an α-N-sulfonylamino-β-hydroxy carboxylic acid.

5. A process according to claim 1 wherein chiral bidentate ligand has a concentration between 1 mol % and 10 mol %, with respect to the olefin substrate.

6. A process according to claim 5 wherein, in said Step A, the chiral bidentate ligand has a concentration of 5 mol %, with respect to the olefin substrate.

7. A process according to claim 6 wherein, in said Step B, the osmium tetraoxide has a concentration of between 0.1 mol % and 1 mol %, with respect to the olefin substrate.

8. A process according to claim 7 wherein, in said Step B, the osmium tetraoxide has a concentration of approximately 0.2 mol %, with respect to the olefin substrate.

9. A process according to claim 8 , wherein the olefin substrate is an α,β-unsaturated carboxylic acid ester.

10. A process according to claim 9 wherein the pH of the reaction mixture of said Step B is approximately 5.

11. A process according to claim 10 wherein the alcohol used in the alcohol/water solvent mixture of said Step A is tertiary butyl alcohol.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 20, 2016
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039082/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2001
From: SHARPLESS, K. BARRY; FOKIN, VALERY; ANDERSSON, MALIN; EPPLE, ROBERT
To: SCRIPPS RESEARCH INSTITUTE, THE
Reel/Frame 012394/0695 →
Continuity (2)
Provisional Application 6023755400 · Oct 2, 2000
Related Publication 20020042545A1 · Apr 11, 2002